Evoke Pharma Inc (EVOK)
0.441
-0.01
(-3.08%)
USD |
NASDAQ |
Apr 23, 16:00
Evoke Pharma Revenue (TTM): 5.181M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.181M |
| September 30, 2023 | 4.301M |
| June 30, 2023 | 3.570M |
| March 31, 2023 | 2.901M |
| December 31, 2022 | 2.509M |
| Date | Value |
|---|---|
| September 30, 2022 | 2.073M |
| June 30, 2022 | 2.171M |
| March 31, 2022 | 1.946M |
| December 31, 2021 | 1.618M |
| September 30, 2021 | 1.280M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.280M
Minimum
Sep 2021
5.181M
Maximum
Dec 2023
2.755M
Average
2.340M
Median
Revenue (TTM) Benchmarks
| Eton Pharmaceuticals Inc | 31.64M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 7.098M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |